Oric Pharmaceuticals, Inc. — All Filings
394 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | 424B3 | 0001193125-25-145721 | Jun 24, 2025 | — |
| 4 | — | 0001415889-25-018014 | Jun 23, 2025 | Jun 20, 2025 |
| EFFECT | — | 9999999995-25-001981 | Jun 20, 2025 | — |
| CORRESP | — | 0001193125-25-142046 | Jun 17, 2025 | — |
| UPLOAD | — | 0000000000-25-006298 | Jun 16, 2025 | — |
| 8-K | 8-K | 0001193125-25-140725 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017325 | Jun 13, 2025 | Jun 12, 2025 |
| 4 | — | 0001415889-25-016739 | Jun 11, 2025 | Jun 10, 2025 |
| S-3 | S-3 | 0001193125-25-139139 | Jun 11, 2025 | — |
| 4 | — | 0001415889-25-016386 | Jun 9, 2025 | Jun 6, 2025 |
| D | — | 0001796280-25-000001 | Jun 6, 2025 | — |
| 144 | — | 0001968582-25-000467 | Jun 6, 2025 | — |
| SCHEDULE 13D | — | 0000950170-25-082520 | Jun 5, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-002631 | Jun 4, 2025 | — |
| SCHEDULE 13G | — | 0001415889-25-015010 | May 30, 2025 | — |
| 8-K | 8-K | 0001193125-25-129531 | May 28, 2025 | May 23, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-012988 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000905148-25-001761 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-013266 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-063564 | May 5, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-063540 | May 5, 2025 | — |
| ARS | ARS | 0001193125-25-091384 | Apr 23, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001193125-25-091359 | Apr 23, 2025 | Jun 11, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-091370 | Apr 23, 2025 | — |
| S-8 | S-8 | 0001193125-25-059251 | Mar 20, 2025 | — |
| 8-K | 8-K | 0001193125-25-054784 | Mar 14, 2025 | Mar 11, 2025 |
| 4 | — | 0001415889-25-006616 | Mar 4, 2025 | Mar 3, 2025 |
| 8-K | 8-K | 0001193125-25-035203 | Feb 25, 2025 | — |
| 10-K | 10-K | 0000950170-25-022273 | Feb 18, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-022219 | Feb 18, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000894 | Feb 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-005028 | Jan 13, 2025 | — |
| 4 | — | 0001415889-25-000795 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000782 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000785 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000788 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000792 | Jan 6, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000602 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000600 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000601 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-24-029631 | Dec 17, 2024 | Dec 15, 2024 |
| 4 | — | 0001415889-24-029633 | Dec 17, 2024 | Dec 15, 2024 |
| 4 | — | 0001415889-24-029634 | Dec 17, 2024 | Dec 15, 2024 |
| 144 | — | 0001796280-24-000005 | Dec 16, 2024 | — |
| 144 | — | 0001796280-24-000006 | Dec 16, 2024 | — |
| 144 | — | 0001796280-24-000007 | Dec 16, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119315 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-258788 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000935836-24-000716 | Nov 14, 2024 | — |
| SC 13G/A | ORIC PHARMACEUTICALS, INC. | 0000902664-24-006454 | Nov 13, 2024 | — |